| abstract |
An object of the present invention is to prevent and treat hepatitis C by inhibiting the entry of HCV into host cells. The present invention provides an inhibitor of HCV entry into a host cell, comprising a phenylcarbamoyl derivative represented by the following general formula (I) or a pharmaceutically acceptable salt thereof. [Chemical 1] [Wherein, R 1 represents an aryl group or a heteroaryl group substituted or unsubstituted with a substituent, and R 2 represents hydrogen, halogen, a lower alkyl group, a lower alkenyl group, or a lower alkynyl group. , X 1 and X 2 each independently represents O, S, NH or CH 2 ] [Selection figure] None |